查詢結果分析
來源資料
相關文獻
- 血液透析之鐵劑輸注療法
- 血液透析患者合併地中海貧血之治療
- 血液透析患者的貧血問題
- The Clinical Experience of Higher rHuEPO Dosage in Chronic Hemodialysis Patients with Epo-Hyporesponsiveness
- Serum Transferrin Receptor is a Good Index of Erythropoietin Treatment in ESRD
- Assessment of Serum Erythropoietin Level in Chronic Hemodialysis Patients
- 降低血液透析病患紅血球生成素使用之改善專案
- Effect of Rocombinant Human Erythropoietin in Severe Anemic and Iron- Dverloaded Patients on Maintenance Hemodialysis
- 血液透析患者鐵劑的補充與護理
- Intravenous Iron Dextran is Superior to Oral Ferrous Sulfate in the Correction of Anemia in Hemodialysis Patients
頁籤選單縮合
題 名 | 血液透析之鐵劑輸注療法=Parenteral Iron Therapy in Hemodialysis |
---|---|
作 者 | 洪佳齊; 詹雅婷; 黃小倩; 吳明修; | 書刊名 | 腎臟與透析 |
卷 期 | 27:2 2015.06[民104.06] |
頁 次 | 頁65-69 |
分類號 | 415.816 |
關鍵詞 | 貧血; 血液透析; 鐵劑補充; Anemia; Hemodialysis; Iron supplement; |
語 文 | 中文(Chinese) |
中文摘要 | 嚴重缺鐵性貧血會增加病人的住院率、心血管疾病、死亡率並影響生活品質,故鐵劑的補充對於血液透析病人十分重要!病人常因注射鐵劑而導致血壓降低、皮膚搔癢、蕁麻疹或引發腸胃副作用等非致命性不良反應,而拒絕接受鐵劑治療,引發探究透析病人缺鐵性貧血之原因、補充鐵劑類型、注意及劑量安全用法、用藥副作用、鐵劑治療時的護理與注意事項以及鐵劑給藥技術等知能,期望對醫護人員在日後臨床工作中有所裨益。 |
英文摘要 | Severe iron deficiency anemia (IDA) will increase patient's hospitalization rate, cardiovascular disease, mortality rate and influence the life quality. Thus, iron supplement is crucial for patients receiving hemodialysis. However, the non-fatal adverse events caused by iron injection such as hypotension, skin itching, urticaria and gastrointestinal upset often result in patients' refusal of iron supplement. This article aimed at the causes of IDA in patients on hemodialysis, the indications of iron supplement, the choices of parental iron preparations, dosing, precautions and adverse effects. Moreover, the administration technique and nursing information were reviewed in this article, and we hope these provide helpful information for physicians and nursing staffs in clinical practice. |
本系統中英文摘要資訊取自各篇刊載內容。